1
项与 VRP adjuvant vaccination(Global Vaccines, Inc.) 相关的临床试验Phase I/II study of VEGFR1/2-derived peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for metastatic colorectal cancer with KRAS genetic mutation as a third-line therapy - Phase I/II study of peptide vaccination in combination with TS-1 for metastatic colorectal cancer with KRAS genetic mutation
100 项与 VRP adjuvant vaccination(Global Vaccines, Inc.) 相关的临床结果
100 项与 VRP adjuvant vaccination(Global Vaccines, Inc.) 相关的转化医学
100 项与 VRP adjuvant vaccination(Global Vaccines, Inc.) 相关的专利（医药）
100 项与 VRP adjuvant vaccination(Global Vaccines, Inc.) 相关的药物交易
